Phase I/IIa clinical study of BriaCell’s lead candidate, Bria-IMT™, with Incyte Corporation’s immune checkpoint inhibitor, INCMGA00012, is ongoing and recruiting […]
Highlights:Little Green Pharma completes commissioning of cultivation facility expansion on time and on budgetExpanded cultivation facility will allow production of […]
Key highlights:The sale of Yard Management will strengthen TrackX balance sheet Creates joint sales and marketing opportunities through FourKites expansive networkEnables […]